日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer

PROTAC 介导的 BCL-xL 和 BCL-2 双重降解是小细胞肺癌的一种高效治疗策略

Sajid Khan, Lin Cao, Janet Wiegand, Peiyi Zhang, Maria Zajac-Kaye, Frederic J Kaye, Guangrong Zheng, Daohong Zhou

PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer

PROTAC 介导的 BCL-xL 和 BCL-2 双重降解是小细胞肺癌的一种高效治疗策略

Sajid Khan, Lin Cao, Janet Wiegand, Peiyi Zhang, Maria Zajac-Kaye, Frederic J Kaye, Guangrong Zheng, Daohong Zhou

TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background

TYMS 在 Ink4a/Arf 无效背景下促进基因组不稳定性和肿瘤进展

Maria V Guijarro #, Akbar Nawab #, Peter Dib, Sandra Burkett, Xiaoping Luo, Michael Feely, Elham Nasri, Robert P Seifert, Frederic J Kaye, Maria Zajac-Kaye

Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice

将 BCL-XL 和 MCL-1 与 DT2216 和 AZD8055 共同靶向可协同抑制小细胞肺癌生长,且不会在小鼠中引起靶向毒性

Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine Hann, Maria Zajac-Kaye, Frederic J Kaye, Daohong Zhou

Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival

胸苷酸合酶加速 Men1 介导的胰腺肿瘤进展并降低生存率

Vinod Vijayakurup, Kyungah Maeng, Hye Seung Lee, Benjamin Meyer, Sandra Burkett, Akbar Nawab, Michael W Dougherty, Christian Jobin, Iqbal Mahmud, Timothy J Garrett, Michael Feely, Kyoung Bun Lee, Frederic J Kaye, Maria V Guijarro, Maria Zajac-Kaye

Reducing Chemotherapy-Induced DNA Damage via nAChR-Mediated Redox Reprograming-A New Mechanism for SCLC Chemoresistance Boosted by Nicotine

通过 nAChR 介导的氧化还原重编程减少化疗引起的 DNA 损伤 - 尼古丁增强 SCLC 化疗耐药性的新机制

Yuzhi Wang, Tengfei Bian, Lina Song, Yunhan Jiang, Zhiguang Huo, Ramzi G Salloum, Graham W Warren, Frederic J Kaye, Naomi Fujioka, Lingtao Jin, Chengguo Xing

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

肿瘤浸润淋巴细胞治疗抗 PD-1 耐药转移性肺癌:一项 1 期临床试验

Benjamin C Creelan #, Chao Wang #, Jamie K Teer, Eric M Toloza, Jiqiang Yao, Sungjune Kim, Ana M Landin, John E Mullinax, James J Saller, Andreas N Saltos, David R Noyes, Leighann B Montoya, Wesley Curry, Shari A Pilon-Thomas, Alberto A Chiappori, Tawee Tanvetyanon, Frederic J Kaye, Zachary J Thomps

Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma

靶向人类粘液表皮样癌中的 Notch 和 EGFR 信号

Wei Ni, Zirong Chen, Xin Zhou, Rongqiang Yang, Mu Yu, Jianrong Lu, Frederic J Kaye, Lizi Wu

Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

人类和小鼠LKB1失活肺癌对异常CRTC-CREB激活的依赖性

Xin Zhou ,Jennifer W Li ,Zirong Chen ,Wei Ni ,Xuehui Li ,Rongqiang Yang ,Huangxuan Shen ,Jian Liu ,Francesco J DeMayo ,Jianrong Lu ,Frederic J Kaye ,Lizi Wu

The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma

CRTC1-MAML2 融合是粘液表皮样癌的主要致癌驱动因素

Zirong Chen, Wei Ni, Jian-Liang Li, Shuibin Lin, Xin Zhou, Yuping Sun, Jennifer W Li, Marino E Leon, Maria D Hurtado, Sergei Zolotukhin, Chen Liu, Jianrong Lu, James D Griffin, Frederic J Kaye, Lizi Wu